ARTICLE | Deals
European translation sees more money but fewer start-ups in 2020
Academia remains the primary source of innovation, but industry spinouts rose in number last year
May 1, 2021 3:30 AM UTC
Europe enjoyed the global funding bonanza for new biotechs in 2020, but its pace of company creation is slowing, with a 20% drop since 2017. And while academia continued last year to dominate in providing the technology for start-ups, industry’s contribution rose to almost one quarter of the new companies funded.
The trends suggest that Europe has still not solved its translational problem — the discrepancy between the high level of academic research and the region’s ability to convert innovative science into new companies. ...